echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Two pharmaceutical companies on the same day "shot" siege of 5 billion varieties.

    Two pharmaceutical companies on the same day "shot" siege of 5 billion varieties.

    • Last Update: 2020-09-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network August 17th, August 12th, Hainan Bett Pharmaceuticals, Wuhan Qirui Pharmaceuticals to imitate the 4 categories submitted by the injection of Voliconazole listing application was accepted by CDE.
    2019, China's public medical institutions terminal antifungal antifungal drug TOP10 products, injection of volicazole with 29% of the market share in the first place.
    Figure 1: August 12 injection with voliconazole contractor source: CDE official website Voliconazole is a broad spectrum of triamcinolone antifungal drugs, can inhibit the biosynthesis of the fungus mcprentol and play an antifungal role, candida, trimycinol and other fungi have a bactericidal effect, is the treatment of serious trimycin infection of the first-line drugs.
    the current domestic market sales of the main dosage form of Voliconazole capsules, tablets, injections, dry suspension and so on. according to
    meters intranet data, in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminals Voliconzo sales of more than 5 billion yuan, of which injections exclusively "half of the wall."
    in the whole body antifungal drug TOP10 products, injection volicazole with 29% of the market share in the first place.
    At present, there are 5 enterprises in the domestic market with injection of Volliconazole production approval, no enterprise's products have been evaluated, nor have enterprises submitted a consistent evaluation supplementary application, but 7 enterprises to copy 4 categories to submit the product listing application, if approved for listing, will be treated as through consistency evaluation.
    Figure 2: New classification of voliconazole for injection source: Minet one-click search from the contractor date, Qilu Pharmaceuticals in July 2018 the first to submit a new classification of the market application for injection volicazole, Hainan Puli Pharmaceutical followed immediately.
    , Hainan Pte Pharmaceuticals submitted an application for the product to be launched in August 2019 and again on August 12, 2020, presumably for new product planning.
    source: In-net database note: data statistics as of August 14, if there are omissions, welcome to point the right!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.